Mechanistic and metabolic inferences from the binding of substrate analogues and products to arginase

被引:70
作者
Cox, JD
Cama, E
Colleluori, DM
Pethe, S
Boucher, JL
Mansuy, D
Ash, DE
Christianson, DW [1 ]
机构
[1] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA
[2] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA
[3] Univ Paris 05, UMR 8601, F-75270 Paris 06, France
关键词
D O I
10.1021/bi002318+
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Arginase is a binuclear Mn2+ metalloenzyme that catalyzes the hydrolysis of L-arginine to L-ornithine and urea. X-ray crystal structures of arginase complexed to substrate analogues N-omega-hydroxy-L-arginine and N-omega-hydroxy-nor-L-arginine, as well as the products L-ornithine and urea, complete a set of structural "snapshots" along the reaction coordinate of arginase catalysis when interpreted along with the X-ray crystal structure of the arginase-transition-state analogue complex described in Kim et;II. [Kim, N. N., Cox, J. D., Baggie, R. F., Emig, F. A., Mistry, S., Harper, S. L., Speicher, D. W., Morris, Jr., S. M., Ash, D. E., Traish, A. M., and Christianson, D. W. (2001) Biochemistry 40, 2678-2688]. Taken together, these structures render important insight on the structural determinants of tight binding inhibitors. Furthermore, we demonstrate for the first time the structural mechanistic link between arginase and NO synthase through their respective complexes with N-omega-hydroxy-L-arginine. That N-omega-hydroxy-L-arginine is a catalytic intermediate for NO synthase and an inhibitor of arginase reflects the reciprocal metabolic relationship between these two critical enzymes of L-arginine catabolism.
引用
收藏
页码:2689 / 2701
页数:13
相关论文
共 79 条
[1]  
ALBINA JE, 1995, J IMMUNOL, V155, P4391
[2]  
ALBINA JE, 1990, J IMMUNOL, V144, P3877
[3]   SYSTEMATIC ANALYSIS OF STRUCTURAL DATA AS A RESEARCH TECHNIQUE IN ORGANIC-CHEMISTRY [J].
ALLEN, FH ;
KENNARD, O ;
TAYLOR, R .
ACCOUNTS OF CHEMICAL RESEARCH, 1983, 16 (05) :146-153
[4]  
Ash DE, 2000, MET IONS BIOL SYST, V37, P407
[5]   A new chromophoric assay for arginase activity [J].
Baggio, R ;
Cox, JD ;
Harper, SL ;
Speicher, DW ;
Christianson, DW .
ANALYTICAL BIOCHEMISTRY, 1999, 276 (02) :251-253
[6]  
Baggio R, 1999, J PHARMACOL EXP THER, V290, P1409
[7]   Inhibition of Mn-2(2+)-arginase by borate leads to the design of a transition state analogue inhibitor, 2(S)-amino-6-boronohexanoic acid [J].
Baggio, R ;
Elbaum, D ;
Kanyo, ZF ;
Carroll, PJ ;
Cavalli, RC ;
Ash, DE ;
Christianson, DW .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (34) :8107-8108
[8]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[9]   Crystal structures of Bacillus caldovelox arginase in complex with substrate and inhibitors reveal new insights into activation, inhibition and catalysis in the arginase superfamily [J].
Bewley, MC ;
Jeffrey, PD ;
Patchett, ML ;
Kanyo, ZF ;
Baker, EN .
STRUCTURE WITH FOLDING & DESIGN, 1999, 7 (04) :435-448
[10]   FORMATION OF NITROGEN-OXIDES AND CITRULLINE UPON OXIDATION OF N-OMEGA-HYDROXY-L-ARGININE BY HEMEPROTEINS [J].
BOUCHER, JL ;
GENET, A ;
VADON, S ;
DELAFORGE, M ;
MANSUY, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (03) :1158-1164